![Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity](https://mma.prnewswire.com/media/2308428/image_2.jpg?p=facebook)
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
![Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-02026-4/MediaObjects/41591_2022_2026_Fig2_HTML.png)
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine
![Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | Diabetologia Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | Diabetologia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-020-05224-2/MediaObjects/125_2020_5224_Figa_HTML.png)
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | Diabetologia
![What we're doing to speed up clinical trials in the UK – Department of Health and Social Care Media Centre What we're doing to speed up clinical trials in the UK – Department of Health and Social Care Media Centre](https://healthmedia.blog.gov.uk/wp-content/uploads/sites/169/2023/05/ClinicalTrialBlog.png)